Related Experiment Video
Updated: Nov 1, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Structural insights into understudied human cytochrome P450 enzymes
David Machalz1, Szymon Pach1, Marcel Bermudez1
1Pharmaceutical and Medicinal Chemistry (Computer-Aided Drug Design), Institute of Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.
This review explores understudied cytochrome P450 (CYP) enzymes, highlighting recent structural insights. Understanding these CYP structures reveals opportunities for structure-based drug design and targeting new therapies.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Human cytochrome P450 (CYP) enzymes are crucial for metabolizing drugs, xenobiotics, and endogenous compounds.
- CYPs play significant roles in various pathophysiological pathways, making them therapeutically relevant targets.
- Many promising CYP targets remain understudied and untargeted despite their therapeutic potential.
Purpose of the Study:
- To summarize and highlight structural knowledge of cytochrome P450 enzymes.
- To focus on understudied CYPs and their potential as drug targets.
- To explore opportunities for structure-based drug design using novel CYP structural data.
Main Methods:
- Review of recent X-ray and cryo-electron microscopy (EM) structures of CYPs.
- Analysis of structural data to understand CYP function and ligand binding.
- Integration of molecular modeling to explain pathophysiological effects.
Main Results:
- Recent structural data provide new insights into CYP function and ligand interactions.
- Structural knowledge is key to understanding CYP metabolism and identifying new drug targets.
- Molecular modeling aids in mechanistically linking CYP function to disease.
Conclusions:
- Understudied CYPs represent significant untapped potential for therapeutic intervention.
- Structure-based drug design utilizing novel CYP structures can accelerate drug discovery.
- Further research into CYP structures will enable the development of targeted therapies.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
Related Concept Videos
Introduction to Mechanisms of Enzyme Catalysis
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Drug Metabolism: Phase I Reactions
Introduction to Enzymes
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
Catalytically Perfect Enzymes
Most enzymes...
Introduction to Enzyme Kinetics
The experimenter can then plot the initial reaction rate or velocity (Vo) of a given trial against the substrate concentration ([S]) to obtain a graph of the reaction properties. For many enzymatic reactions involving a...